Hongzhi Geng

A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Depei Wu, Xiaowen Tang, Jin Zhou, 2021, Frontiers in Oncology.

Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma

Kailin Xu, Zhenyu Li, Xiangmin Wang, 2022, Frontiers in Immunology.